title: Ex vivo evidence that the phosphodiesterase inhibitor IBMX attenuates the up-regulation of PAR-2 in the endotoxemic rat aorta.
authors.forename: A
authors.initials: A
authors.lastname: Kawabata
authors.forename: R
authors.initials: R
authors.lastname: Kuroda
authors.forename: Y
authors.initials: Y
authors.lastname: Nakaya
authors.forename: N
authors.initials: N
authors.lastname: Kawao
authors.forename: H
authors.initials: H
authors.lastname: Nishikawa
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D019446:Endotoxemia / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D012333:RNA, Messenger / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin / Q000235:genetics / Q000502:physiology*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D010726:Phosphodiesterase Inhibitors; D012333:RNA, Messenger; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin; D015056:1-Methyl-3-isobutylxanthine